# Prevalence of Germline Alterations in Actionable Genes in Endometrial Cancer

> **NCT07066969** · NA · NOT_YET_RECRUITING · sponsor: **European Institute of Oncology** · enrollment: 20 (estimated)

## Conditions studied

- Endometrial Cancer

## Interventions

- **GENETIC:** Sophia DDM

## Key facts

- **NCT ID:** NCT07066969
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-22
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07066969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07066969, "Prevalence of Germline Alterations in Actionable Genes in Endometrial Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07066969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*